Compare LNSR & APYX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LNSR | APYX |
|---|---|---|
| Founded | 2004 | 1982 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical Electronics | Medical/Dental Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 146.7M | 169.6M |
| IPO Year | 2005 | 1995 |
| Metric | LNSR | APYX |
|---|---|---|
| Price | $5.60 | $4.47 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 4 |
| Target Price | ★ $10.00 | $6.50 |
| AVG Volume (30 Days) | 48.2K | ★ 195.4K |
| Earning Date | 05-11-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 19.40 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $58,435,000.00 | N/A |
| Revenue This Year | $10.06 | $11.93 |
| Revenue Next Year | $41.48 | $11.01 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 9.24 | N/A |
| 52 Week Low | $5.06 | $1.59 |
| 52 Week High | $13.47 | $4.50 |
| Indicator | LNSR | APYX |
|---|---|---|
| Relative Strength Index (RSI) | 41.81 | 61.61 |
| Support Level | $5.34 | $3.39 |
| Resistance Level | $6.20 | N/A |
| Average True Range (ATR) | 0.22 | 0.32 |
| MACD | -0.00 | 0.03 |
| Stochastic Oscillator | 5.65 | 81.48 |
LENSAR Inc is a commercial-stage medical device company focused on designing, developing, and marketing a femtosecond laser system for the treatment of cataracts. The company Laser System incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes, efficiency, and reproducibility by providing imaging, simplified procedure planning, efficient design, and precision. Its product portfolio consists of the LENSAR Laser System with Streamline IV and IntelliAxis and its associated consumable components. Geographically, the company generates the majority of its revenue from the United States, followed by Europe and Asia.
Apyx Medical Corp is an energy technology medical device company. It specializes in developing, manufacturing, and marketing a range of cosmetic and surgical products and technologies, as well as related medical products used in doctor's offices, surgery centers, and hospitals. Its product offerings comprise Renuvion cosmetic technology, which offers plastic surgeons, facial plastic surgeons, and cosmetic physicians the ability to provide controlled heat to the tissue to achieve desired results. The J-Plasma system allows surgeons to operate with a high level of precision and virtually eliminates unintended tissue trauma. It operates in two segments namely: Surgical Aesthetics and Original Equipment Manufacturing (OEM). Its Surgical Aesthetics segment derives the majority of its revenue.